Skip to main content
Clinical Trials/ISRCTN13120555
ISRCTN13120555
Active, not recruiting
未知

The efficacy of peroneal nerve functional electrical stimulation for the reduction of bradykinesia in Parkinson’s disease: An assessor-blinded randomised controlled trial

Salisbury NHS Foundation Trust0 sites234 target enrollmentSeptember 8, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Parkinson's disease
Sponsor
Salisbury NHS Foundation Trust
Enrollment
234
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 8, 2023
End Date
September 30, 2026
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Current participant inclusion criteria as of 13/10/2023:
  • 1\. Aged 18 years and above (no upper age limit)
  • 2\. Idiopathic Parkinson’s disease
  • 3\. Hoehn and Yahr stages I to IV under medication
  • 4\. Difficulty in walking due to Parkinson’s disease bradykinesia, defined as a measured 10m walking speed (10mWS) of less than 1\.25ms\-1
  • 5\. Able to walk 10m with appropriate walking aids, but without assistance from another person
  • 6\. Able to obtain standing from sitting without the assistance of another person
  • 7\. Able to understand and comply with the treatment and assessment procedures
  • 8\. Able to give informed consent
  • Previous participant inclusion criteria:

Exclusion Criteria

  • Current participant exclusion criteria as of 13/10/2023:
  • 1\. Receiving, or scheduled to start, deep brain stimulation, within the next 6 months
  • 2\. Receiving or scheduled to start apomorphine or duodopa within the next 6 months (those who are currently taking duodopa and apomorphine are eligible)
  • 3\. Pyramidal and/or extrapyramidal systems injuries
  • 4\. Untreated or refractory epilepsy with seizures in the last 3 months
  • 5\. Pregnancy or planned pregnancy
  • 6\. Cardiac pacemaker, or other active medical implanted devices
  • 7\. Denervation of the common peroneal nerve, or other neurological condition known to cause dropped foot
  • 8\. Severe osteoarticular pathology that involves the calf bones, knee and tibiotarsal joints, or other conditions that significantly affect walking
  • 9\. Malignancy or dermatological conditions in the leg that would be stimulated

Outcomes

Primary Outcomes

Not specified

Similar Trials